GM’s Q3 Volume Remains Below Consensus and 4 Stock Analyses Buzzing Today
Cabela’s Inc. (NYSE:CAB): After Wells Fargo attended the opening of Cabela’s first Outpost store, it believes that the company has the ability to open hundreds of the stores along with using a few of the store’s features in the remainder of the chain. The firm keeps its Outperform rating on the stock.
General Motors Corporation (NYSE:GM): According to Credit Suisse, Q3 vehicle production exceeded expectations although it faces deteriorating sales trends in Europe and rising inventories in Europe and North America. The analyst believes that Q3 over-production will result in Q4 cuts and any commentary concerning volumes will be cautious. The firm continues to be below consensus for General Motors during Q3.
Are these stocks a buy or sell? Let us help you decide. Check out our Wall St. Cheat Sheet Stock Picker Newsletter now >>
Medtronic, Inc. (NYSE:MDT) announced new results from Symplicity HTN-1, which is currently the longest running clinical trial investigating the safety and efficacy of renal denervation. The data indicated that patients receiving renal denervation treatment with the Symplicity system saw a mean blood pressure reduction of -29/-14 mm Hg at 24 months. These data brings the total number of patients to about two times the amount previously reported at 24 months (n=59) from this clinical trial, and the safety of renal denervation with the Symplicity system was also maintained at 24 months. For the first time today, the expanded two year cohort data were presented at the 24th Annual Transcatheter Cardiovascular Therapeutics, TCT, scientific symposium, which was sponsored by the Cardiovascular Research Foundation. The Symplicity system is currently only allowed for investigational use in the U.S.
Brinker International Inc. (NYSE:EAT) is viewed by Wells Fargo as one of the few restaurant chains that is in the position to take market share and expand its margins during FY13. The firm expects Brinker’s Q1 EPS to surpass the consensus estimate, and it reiterates its Outperform rating on the stock.
Dunkin’ Brands Group Inc (NASDAQ:DNKN) multiple is predicted by Wells Fargo expects Dunkin’ Brands’ multiple to advance during 2013, this is mainly a result o what it believes is high visibility into continued mid-teens EPS growth in 2013 and 2014. The firm keeps its Outperform rating on the stock.
Don’t Miss: Ford and GM Race to Win This Emerging Market.